PHARMAC-HRC research partnership

Details

The Health Research Council of New Zealand (HRC) and PHARMAC have formed a joint research initiative to support innovative research and advance the strategic objectives of both organisations. It is anticipated that this partnership will augment PHARMAC’s focus on securing best health outcomes from pharmaceuticals (including obtaining value from new and existing treatments), and build on HRC investment to strengthen the use of research evidence to improve New Zealand’s health system.

The funding partners for this RFP anticipate that successful research projects will target one or more of the following research priority areas. The RFP priority areas listed reflect key challenges facing PHARMAC and the New Zealand health sector where research could make an important contribution.

• Improving pharmaceutical adherence.
• Improving optimal use of pharmaceuticals.
• Measuring the impact of PHARMAC’s decisions on health outcomes.
• Improving the value for money from currently funded pharmaceuticals.

A total funding pool of approximately $427,500 (exclusive of GST) is available for allocation. The funding partners invite applications for funding of up to $213,750 (exclusive of GST) and duration of up to 24 months.

Applications to this RFP will be submitted via a one-stage process. Applicants are firstly required to submit a Registration via the HRC’s online portal HRC Gateway. Registrations are due 1pm, Tuesday 14 November 2017. The full application will need to be submitted via the HRC Gateway by 1pm, Tuesday 28 November 2017.

Please refer to the RFP for more information. The RFP, application forms and the application guidelines are available on the HRC website http://www.hrc.govt.nz/funding-opportunities/requests-for-proposals